Free shipping on all orders over $ 500

AZD 1283

Cat. No. M6480

All AbMole products are for research use only, cannot be used for human consumption.

AZD 1283 Structure
Size Price Availability Quantity
5mg USD 130  USD130 In stock
10mg USD 210  USD210 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

AZD 1283 is a high affinity P2Y12 antagonist (Kd = 11 nM). Causes a dose-dependent increase in blood flow and inhibits ADP-induced platelet aggregation in vivo. Antithrombotic.

Chemical Information
Molecular Weight 470.54
Formula C23H26N4O5S
CAS Number 919351-41-0
Form Solid
Solubility (25°C) DMSO 47.05 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Naya, et al. J Med Chem. Design, synthesis, and discovery of a novel CCR1 antagonist.

Related P2 Receptor Products
NF449 

NF449 is a highly potent P2X1 receptor antagonist, with IC50s of 0.28, 0.69, and 120 nM for rP2X1, rP2X1+5, P2X2+3, respectively.

NF279 

NF279 is a potent selective and reversible P2X1 receptor antagonist, with an IC50 of 19 nM.

NF110 

NF110 is a P2X3 receptor antagonist (Ki = 36 nM) and inactive toward P2Y receptors stably expressed (IC50s > 10 M).

PSB-12062

PSB-12062 is a potent and selective P2X4 antagonist with an IC50 of 1.38 μM for human P2X4.

NF449 octasodium 

NF449 octasodium is a highly potent P2X1 receptor antagonist, with IC50s of 0.28, 0.69, and 120 nM for rP2X1, rP2X1+5, P2X2+3, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: AZD 1283 supplier, P2 Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.